About this trial
In France, one in 4500 women is affected by the MayerRokitantskyKüsterHauser (MRKH) syndrome which is characterized by the absence of uterus at birth. Currently, the only solutions for these patients are:
* Gestational surrogacy, prohibited in France * Adoption * Resignation
Uterine transplantation could become a good alternative.
This study is conducted in 10 patients with MRKH type I syndrome, who will be transplanted from a living donor uterus
Eligibility criteria
Qualifiers
Being aged between 18 and 38 years old
In stable couple, with a pregnancy project, favorable psychological evaluation
No history of cancer and transfusion
Absence of comorbidity (neurological, nephro-urological pathology, infectious, psychiatric or psychological pathology)
Disqualifiers
Extreme oligo-astheno-spermia and azoospermia in the husband
History of abdominopelvic surgery excluding uncomplicated appendectomy; vaginal residue not allowing anastomosis
Known thromboembolic risk factor
No Compatibility with the recipient (group, rhesus, HLA)
Trial design
Treatments tested in this trial
- Uterine transplantation